Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 401–500 of 1,001
Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
Awoniyi, O., Rehman, R., & Dagogo-Jack, S. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0411-y · Cited by 59
Choudhary, P., & Amiel, S. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4566-6 · Cited by 52
Artificial pancreas: an emerging approach to treat Type 1 diabetes
Kumareswaran, K., Evans, M. L., & Hovorka, R. (2009) · Expert Review of Medical Devices · doi:10.1586/erd.09.23 · Cited by 60
Biosensing Technologies for Medical Applications, Manufacturing, and Regenerative Medicine
Shafiee, A., Ghadiri, E., Kassis, J. N., Zarandi, N. P., & Atala, A. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0123-y · Cited by 56
PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months
Gu, B., Papadimitrakopoulos, F., & Burgess, D. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.021 · Cited by 53
Heise, H. M., Delbeck, S., & Marbach, R. (2021) · Biosensors · doi:10.3390/bios11030064 · Cited by 60
Continuous Glucose Monitoring in Insulin-Treated Patients in Non-ICU Settings
Gomez, A. M., & Umpierrez, G. E. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814546025 · Cited by 51
Secher, A. L., Madsen, A. B., Ringholm, L., Barfred, C., Stage, E., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03426.x · Cited by 51
Parental Attitudes Towards Overnight Closed-Loop Glucose Control in Children with Type 1 Diabetes
Elleri, D., Acerini, C. L., Allen, J. M., Hayes, J., Pesterfield, C., Wilinska, M. E., Dunger, D. B., & Hovorka, R. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0084 · Cited by 50
Continuous glucose monitors: current status and future developments
Lane, J. E., Shivers, J. P., & Zisser, H. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835edb9d · Cited by 50
on behalf of the CONCEPTT Collaborative Group, Feig, D. S., Asztalos, E., Corcoy, R., De Leiva, A., Donovan, L., Hod, M., Jovanovic, L., Keely, E., Kollman, C., et al. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0961-5 · Cited by 49
Tanenbaum, M. L., Adams, R. N., Lanning, M. S., Hanes, S. J., Agustin, B. I., Naranjo, D., & Hood, K. K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818786486 · Cited by 50
Murphy, H. R., Feig, D. S., Sanchez, J. J., de Portu, S., Sale, A., & the CONCEPTT Collaborative Group (2019) · Diabetic Medicine · doi:10.1111/dme.14046 · Cited by 49
Self-citationAccuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age
Tsoukas, M. A., Rutkowski, J., Fathi, A. E., Yale, J., Bernier-Twardy, S., Bossy, A., Pytka, E., Legault, L., & Haidar, A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0262 · Cited by 56
Continuous glucose monitoring in cystic fibrosis – A practical guide
Chan, C. L., Ode, K. L., Granados, A., Moheet, A. A., Moran, A., & Hameed, S. A. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.025 · Cited by 51
Mehmood, S., Ahmad, I., Arif, H., Ammara, U. E., & Majeed, A. (2020) · Applied System Innovation · doi:10.3390/asi3030031 · Cited by 58
Evolution of Devices in Diabetes Management
Penfornis, A., Personeni, E., & Borot, S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0058 · Cited by 49
Perceived Accuracy in Continuous Glucose Monitoring: Understanding the Impact on Patients
Polonsky, W. H., & Hessler, D. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814559302 · Cited by 47
Influences on Technology Use and Efficacy in Type 1 Diabetes
Franklin, V. L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816639315 · Cited by 52
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
McGill, J. B., & Ahmann, A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0090 · Cited by 49
Landau, Z., Abiri, S., Gruber, N., Levy-Shraga, Y., Brener, A., Lebenthal, Y., Barash, G., Pinhas-Hamiel, O., & Rachmiel, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1218-8 · Cited by 48
Little, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
Digging Deeper: The Role of Qualitative Research in Behavioral Diabetes
Ritholz, M. D., Beverly, E. A., & Weinger, K. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0226-7 · Cited by 51
Sheikh, K., Bartz, S. K., Lyons, S. K., & DeSalvo, D. J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5162162 · Cited by 52
“This is a notable limitation since previous studies report that duration of CGM is positively related to reduction in HbA1c [9, 22, 26, 27].”
MethodMunshi, M. N., Slyne, C., DAVIS, D. J., Michals, A. L., Sifre, K., Dewar, R., Atakov-Castillo, A., & Toschi, E. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0246 · Cited by 57
Halford, J., & Harris, C. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0121 · Cited by 47
Hypoglycaemia: current management and controversies
Choudhary, P., & Amiel, S. A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.068197 · Cited by 47
Display of Glucose Distributions by Date, Time of Day, and Day of Week: New and Improved Methods
Rodbard, D. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300619 · Cited by 47
Forlenza, G. P., Argento, N. B., & Laffel, L. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0034 · Cited by 44
Rodrigues, R., de Medeiros, L. A., Cunha, L. M., Garrote-Filho, M. D. S., Neto, M. B., Jorge, P. T., Resende, E. S., & Penha‐Silva, N. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.031 · Cited by 53
Khan, F., Saxl, T., & Pickup, J. C. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.11.035 · Cited by 47
Wearable systems and mobile applications for diabetes disease management
Georga, E. I., Protopappas, V. C., Bellos, C. V., & Fotiadis, D. I. (2014) · Health and Technology · doi:10.1007/s12553-014-0082-y · Cited by 52
The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System
Nakamura, K., & Balo, A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815577812 · Cited by 46
Pumpers, skypers, surfers and texters: technology to improve the management of diabetes in teenagers
Harris, M. A., Hood, K. K., & Mulvaney, S. A. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01599.x · Cited by 46
Dermal Tattoo Biosensors for Colorimetric Metabolite Detection
Yetisen, A. K., Moreddu, R., Seifi, S., Jiang, N., Vega, K. C., Dong, X., Dong, J., Butt, H., Jakobi, M., Elsner, M., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201904416 · Cited by 48
Polonsky, W. H., & Fisher, L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0620-7 · Cited by 49
Avula, M., Rao, A. N., McGill, L. D., Grainger, D. W., & Solzbacher, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.090 · Cited by 48
From Wary Wearers to d-Embracers: Personas of Readiness to Use Diabetes Devices
Tanenbaum, M. L., Adams, R. N., Iturralde, E., Hanes, S. J., Barley, R. C., Naranjo, D. M., & Hood, K. K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818793756 · Cited by 49
GluGAN: Generating Personalized Glucose Time Series Using Generative Adversarial Networks
Zhu, T., Li, K., Herrero, P., & Georgiou, P. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3271615 · Cited by 56
Rachmiel, M., Landau, Z., Boaz, M., Aronovitch, K. M., Loewenthal, N., Ben‐Ami, M., Levy‐Shraga, Y., Modan‐Moses, D., Haim, A., Abiri, S., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0643-6 · Cited by 49
Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia
Maker, A. V., Sheikh, R., & Bhagia, V. (2017) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-017-1603-8 · Cited by 59
Wang, L., Zhu, W., Lu, W., Shi, L., Wang, R., Pang, R., Cao, Y., Wang, F., & Xu, X. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111577 · Cited by 48
MOSQUERA-LOPEZ, C. M., Dodier, R. H., Tyler, N. S., Wilson, L. M., Youssef, J. E., Castle, J. R., & Jacobs, P. G. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0458 · Cited by 54
Prahalad, P., Ebekozien, O., Alonso, G. T., Clements, M., Corathers, S., DeSalvo, D., Desimone, M., Lee, J. M., Lorincz, I., McDonough, R., et al. (2021) · Clinical Diabetes · doi:10.2337/cd21-0026 · Cited by 45
Self-citationCooke, D., Hurel, S. J., Casbard, A., Steed, L., Walker, S., Meredith, S., Nunn, A. J., Manca, A., Sculpher, M., Barnard, M., et al. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02723.x · Cited by 46
Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Ovalle, F. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79371-0 · Cited by 45
Zhao, C., & Yu, C. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2387293 · Cited by 47
Rodbard, D. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14906 · Cited by 47
Benhamou, P., Catargi, B., Delenne, B., Guerci, B., Hanaire, H. P., Jeandidier, N., Leroy, R., Meyer, L., Penfornis, A., Radermecker, R. P., et al. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71538-0 · Cited by 49
Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus
Snogdal, L. S., Folkestad, L., Madsen, R. E., Remvig, L. S., Beck‐Nielsen, H., Thorsteinsson, B., Jennum, P., Gjerstad, M. D., & Juhl, C. B. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.04.014 · Cited by 50
Leelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Haidar, A., Evans, M. L., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0221 · Cited by 44
Patients' Perception and Future Acceptance of an Artificial Pancreas
van Bon, A. C., Kohinor, M. J. E., Hoekstra, J. B. L., von Basum, G., & DeVries, J. H. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400313 · Cited by 44
Hypoglycemia: From the Laboratory to the Clinic
Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc09-0113 · Cited by 44
The History, Evolution and Future of Continuous Glucose Monitoring (CGM)
Bender, C., Vestergaard, P., & Cichosz, S. L. (2025) · Diabetology · doi:10.3390/diabetology6030017 · Cited by 43
Interstitial fluid glucose time-lag correction for real-time continuous glucose monitoring
Keenan, D. B., Mastrototaro, J. J., WEINZIMER, S. A., & Steil, G. M. (2012) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2012.05.007 · Cited by 44
CGM, Pregnancy, and Remote Monitoring
Polsky, S., & Garcetti, R. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0023 · Cited by 43
Clements, M. A., Schwandt, A., Donaghue, K. C., Miller, K., Lück, U., Couper, J. J., Foster, N., Schröder, C., Phelan, H., Maahs, D., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12907 · Cited by 43
Carlson, A. L., Kanapka, L. G., Miller, K. M., Ahmann, A. J., Chaytor, N. S., Fox, S., Kiblinger, L., Kruger, D., Levy, C. J., Peters, A. L., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819894974 · Cited by 43
Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes
Kravarusic, J., & Aleppo, G. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.006 · Cited by 42
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
Health Utilities for Children and Adults With Type 1 Diabetes
Lee, J. M., Rhee, K., O’Grady, M. J., Basu, A., Winn, A. N., John, P. M., Meltzer, D. O., Kollman, C., Laffel, L. M., Lawrence, J. M., et al. (2011) · Medical Care · doi:10.1097/mlr.0b013e318216592c · Cited by 42
Diabetes Technology and the Human Factor
Liberman, A., Buckingham, B. A., & Phillip, M. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.1513 · Cited by 46
Katz, M. L., Volkening, L. K., Anderson, B. J., & Laffel, L. M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03646.x · Cited by 42
Pai, P. P., Sanki, P. K., Sarangi, S., & Banerjee, S. (2015) · Review of Scientific Instruments · doi:10.1063/1.4922416 · Cited by 43
Ludwig-Seibold, C., Holder, M., Rami-Merhar, B. M., Raile, K., Heidtmann, B., Holl, R. W., & for the DPV Science Initiative, T. G. W. G. F. I. P. T. I. P. P. A. T. G. B. C. N. D. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00835.x · Cited by 41
Real-Time Glucose Estimation Algorithm for Continuous Glucose Monitoring Using Autoregressive Models
Leal, Y., García-Gabín, W., Bondía, J., Esteve, E., Ricart, W., Fernández‐Real, J. M., & Vehí, J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400221 · Cited by 46
Trajectories of HbA1c Levels in Children and Youth with Type 1 Diabetes
Pinhas‐Hamiel, O., Hamiel, U., Boyko, V., Graph‐Barel, C., Reichman, B., & Lerner‐Geva, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109109 · Cited by 47
Reddy, M., Herrero, P., El-Sharkawy, M., Pesl, P., Jugnee, N., Pavitt, D. V., Godsland, I. F., Alberti, K. G. M. M., Toumazou, C., Johnston, D. G., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815616134 · Cited by 51
Helminen, O., Pokka, T. M.-L., Tossavainen, P. H., Ilonen, J., Knip, M., & Veijola, R. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.027 · Cited by 42
Ng, S. M., Moore, H. S., Clemente, M., Pintus, D., & Soni, A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0347 · Cited by 52
Cichosz, S. L., Jensen, M. H., & Hejlesen, O. K. (2021) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104472 · Cited by 45
Davis, S. N., Horton, E. S., Battelino, T., Rubin, R. R., Schulman, K. A., & Tamborlane, W. V. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0145 · Cited by 40
The changing landscape of automated insulin delivery in the management of type 1 diabetes
Lakshman, R., Boughton, C. K., & Hovorka, R. (2023) · Endocrine Connections · doi:10.1530/ec-23-0132 · Cited by 49
Hypoglycemia in Insulin-Treated Diabetes: A Case for Increased Vigilance
Unger, J., & Parkin, C. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2307 · Cited by 40
Reimbursement for Continuous Glucose Monitoring
Heinemann, L., & DeVries, J. H. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0296 · Cited by 40
Continuous Glucose Monitoring: Impact on Hypoglycemia
van Beers, C. A. J., & DeVries, J. H. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816653411 · Cited by 41
Prahalad, P., Addala, A., Buckingham, B. A., Wilson, D. M., & Maahs, D. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0204 · Cited by 40
Lin, Y. K., Groat, D., Chan, O., Hung, M., Sharma, A., Varner, M. W., Gouripeddi, R., Facelli, J. C., & Fisher, S. J. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz005 · Cited by 39
“The eligibility criteria were T1D, ongoing real-time CGM use for longer than 3 months [6], and active CGM usage time ≥ 86% [2, 13].”
BackgroundInfluentialIntermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
Ziegler, R., Heinemann, L., Freckmann, G., Schnell, O., Hinzmann, R., & Kulzer, B. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905577 · Cited by 39
New and Emerging Technologies in Type 1 Diabetes
Sherwood, J. S., Russell, S. J., & Putman, M. S. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.07.006 · Cited by 49
Glucose measurement in body fluids: A ready reckoner for clinicians
Kubihal, S., Goyal, A., Gupta, Y., & Khadgawat, R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.11.021 · Cited by 47
Limitations of Continuous Glucose Monitor Usage
Anhalt, H. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0011 · Cited by 39
Hermanns, N., Schumann, B., Kulzer, B., & Haak, T. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524105 · Cited by 39
Calhoun, P., Lum, J., Beck, R. W., & Kollman, C. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0042 · Cited by 39
Bronstone, A., & Graham, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633233 · Cited by 38
Smith, M. B., Albanese-O’Neill, A., Macieira, T. G. R., Yao, Y., Abbatematteo, J. M., Lyon, D., Wilkie, D. J., Haller, M. J., & Keenan, G. M. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0136 · Cited by 41
Zhao, Z., Kong, Y., Lin, X., Liu, C., Liu, J., He, Y., Yang, L., Huang, G., & Mei, Y. (2020) · Journal of Materials Chemistry A · doi:10.1039/d0ta09211h · Cited by 39
Visser, H. S. D., Waraich, S., Chhabra, M., Yamamoto, J. M., Zenlea, I. S., Askin, N., Rabbani, R., McGavock, J., TEAM Trial Patient Coresearchers, Greenberg, D. T., et al. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.2740 · Cited by 43
Ritholz, M. D., Beste, M., Edwards, S. S., Beverly, E. A., Atakov‐Castillo, A., & Wolpert, H. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12276 · Cited by 37
Pettus, J., & Edelman, S. V. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0369 · Cited by 38
Dielectric characterization of water glucose solutions using a transmission/reflection line method
Juan, C. G., Bronchalo, E., Torregrosa‐Penalva, G., Ávila-Navarro, E., García-Aracil, N., & Sabater-Navarro, J. M. (2016) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2016.07.011 · Cited by 38
Hirsch, I. B., Balo, A. K., Sayer, K., Garcia, A., Buckingham, B. A., & Peyser, T. A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0080 · Cited by 38
Lin, Y. K., Groat, D., Chan, O. T. M., Hung, M., Sharma, A. R., Varner, M. W., Gouripeddi, R., Facelli, J. C., & Fisher, S. J. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0016 · Cited by 38
Pease, A., Zomer, E., Liew, D., Lo, C., Earnest, A., & Zoungas, S. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01373-y · Cited by 45
Hendrieckx, C., Poole, L. A., Sharifi, A., Jayawardene, D., Loh, M. M., Horsburgh, J. C., Bach, L. A., Colman, P. G., Kumareswaran, K., Jenkins, A. J., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0007 · Cited by 37
Closed loop developments to improve glucose control at home
Renard, É., Cobelli, C., & Kovatchev, B. P. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.009 · Cited by 40
Schreiver, C., Jacoby, U., Watzer, B., Thomas, A., Haffner, D., & Fischer, D. (2012) · Clinical Endocrinology · doi:10.1111/cen.12093 · Cited by 39
Peyser, T. A., Nakamura, K., Price, D., Bohnett, L. C., Hirsch, I. B., & Balo, A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0415 · Cited by 37
Roze, S., Smith-Palmer, J., Valentine, W., Payet, V., de Portu, S., Papo, N., Cucherat, M., & Hanaire, H. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0224 · Cited by 37
Wu, X., Luo, S., Zheng, X., Ding, Y., Wang, S., Ling, P., Yue, T., Xu, W., Yan, J., & Weng, J. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13519 · Cited by 42
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.